Your browser doesn't support javascript.
loading
[Access to liver cancer screening and surveillance in populations in China: an exploratory analysis].
Shi, J F; Cao, M D; Yan, X X; Cao, M M; Wang, Y T; Li, Y J; Wang, X; Li, J B; Li, N; Qu, C F; Chen, W Q.
Affiliation
  • Shi JF; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Cao MD; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Yan XX; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Cao MM; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Wang YT; State Key Laboratory of Molecular Oncology and Department of Immunology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Li YJ; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Wang X; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Li JB; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Li N; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Qu CF; State Key Laboratory of Molecular Oncology and Department of Immunology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Chen WQ; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhonghua Liu Xing Bing Xue Za Zhi ; 43(6): 906-914, 2022 Jun 10.
Article in Zh | MEDLINE | ID: mdl-35725349
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Early Detection of Cancer / Liver Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies / Systematic_reviews Limits: Humans Country/Region as subject: Asia Language: Zh Journal: Zhonghua Liu Xing Bing Xue Za Zhi Year: 2022 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Early Detection of Cancer / Liver Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies / Systematic_reviews Limits: Humans Country/Region as subject: Asia Language: Zh Journal: Zhonghua Liu Xing Bing Xue Za Zhi Year: 2022 Document type: Article Affiliation country: China Country of publication: China